Background: For patients with atrial fibrillation (AF), early treatment is essential to prevent serious complications such as stroke. Several randomized clinical trials have shown that rate-control may be as effective as rhythm-control medications, whereas the latter have serious side effects. Little evidence exists, however, about which class of rate-control medication- -blockers (BBs) or calcium channel blockers (CCBs)-may be superior.

READ FULL ARTICLE Curated publisher From